Unveiling the contributions of immunization for progressing towards Universal Health Coverage

Martin O. C. Otaa Medical Affairs, GSK, Medical Affairs, Wavre, BelgiumCorrespondence[email protected]

Jose C. de Moraesb Department of Collective Health, Faculty of Medical Sciences of Santa Casa de Sao Paulo, Sao Paulo, BrazilView further author information

Ivo Vojteka Medical Affairs, GSK, Medical Affairs, Wavre, Belgium

Dagna Constenlac Medical Affairs, GSK, US Research & Development, Saloui Center, Rockville, MD,USAView further author information

T. Mark Dohertyd Medical Affairs, GSK, Medical Affairs, Brondfby, DenmarkView further author information

Otavio Cintrae Medical Affairs, GSK, Medical Affairs, Rio de Janeiro, BrazilView further author information

Joses M. Kirigiaf African Sustainable Development Research Consortium (ASDRC), Nairobi, KenyaView further author information

Figures & data

Figure 1. United Nations SDG3.^Citation1

SDG, Sustainable Development Goal; WHO, World Health Organization.

Figure 2. Global deaths caused by some of the most common and serious VPDs in 2017.^Citation8

Hib, Haemophilus influenzae type b; TB, tuberculosis; VPD, vaccine-preventable disease.

Figure 3. Global vaccination coverage: Percentage of children aged 1 year vaccinated against VPDs in 2019.^Citation8

BCG, Bacillus Calmette–Guérin; Hib, Hemophilus influenzae type b; TB, tuberculosis; VPD, vaccine-preventable disease.

Figure 4. Increase in the world population relative to 2015, by broad age group, 2015–2100.^Citation20

Supplemental material